I think this is obvious to anyone familiar with bacteria and immunity. The headlines will go for the 'CRISPR is dead" angle, but the work arounds are simple and relatively easy to implement. I think the article is still extremely valuable. It shows that, yes, we target CRISPR just like any other microbiome protein hanging out in a mucus membrane. But it also shows that it's not a threat (or an indicator of a threat).